Elsa
Elsa Science AB operates a CE-marked mobile health platform for patients with chronic rheumatic diseases, offering symptom tracking, medication logging, and science-based self-care programs, with provider-facing remote patient monitoring and research data partnerships with pharma.
- Company typePrivate
- Founded2017
- HeadquartersStockholm, Sweden
- Headcount11–50
- GTM typeB2B and B2C
- OfferingSoftware
What Elsa does
Elsa Science AB, founded in 2017 and headquartered in Stockholm, Sweden, operates a digital health platform built around the CE-marked Elsa Science mobile application, a class I medical device registered with the Swedish Medical Products Agency under the EU Medical Device Regulation. The app targets individuals living with chronic rheumatic conditions — primarily rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and Still's disease — and provides symptom tracking, medication logging, lifestyle-habit correlation, science-based educational programs grounded in cognitive behavioral therapy, and data-sharing features for clinical consultations. The platform is co-developed with patients, rheumatologists, and academic researchers from Karolinska Institutet, Uppsala University, Linköping University, LUMC, and FAU, and is integrated with Apple HealthKit, Google Fit, and Health Connect to ingest wearable activity data.
Elsa has extended its product surface with two adjacent modules: Elsa Rheumatic?, a symptom-screening tool intended to drive early care-seeking, and Elsa Remote Patient Monitoring, a provider-facing module that allows rheumatology teams to track treatment progress in real time and operationalize the treat-to-target clinical approach. The company is structured as a four-sided platform intended to connect patients, healthcare providers, academic researchers, and life science industry partners around shared health data.
Commercially, the consumer app is offered free of charge with no in-app purchases, and the stated revenue model rests on three streams: managed-services partnerships with healthcare providers (anchored by the RPM module), data-monetization and research collaborations with pharmaceutical and diagnostic companies, and credibility-driven partnerships with patient organizations such as the Swedish Rheumatism Association and Unga Reumatiker. Distribution is mobile-first via the iOS App Store and Google Play (5,000+ reported downloads) plus direct field engagement for enterprise healthcare deals. Following a 38.7M SEK (~$4.4M) round in November 2021 led by HealthCap, Elsa initiated a clinical study in Wisconsin as its entry point into the US market, deliberately bypassing the slower Swedish reimbursement pathway. Total disclosed funding since inception is approximately $7.95M across five rounds from 2018 through 2021.
Elsa firmographics
Firmographics- Name
- Elsa
- Legal name
- Elsa Science AB
- Website
- https://elsa.science
- Company type
- Private
- Founded year
- 2017
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Elsa Science AB operates a CE-marked mobile health platform for patients with chronic rheumatic diseases, offering symptom tracking, medication logging, and science-based self-care programs, with provider-facing remote patient monitoring and research data partnerships with pharma.
- Ownership category
- akta.pro rank
Elsa industry classification
Industry- Product category
- Digital Health Patient Self-Management
- NAICS
- Software Publishers (513210), Home Health Care Services (62161)
- SIC
- Services-Health Services (8000), Services-Computer Programming, Data Processing, Etc. (7370)
- akta.pro primary industry
- Chronic Care & Remote Patient Monitoring (RPM) Platforms (HLALABAF)
- akta.pro secondary industries
- Patient Education, Content & Personalized Journey Orchestration (HLACAEAE), Medication Adherence, Digital Therapeutics & Remote Coaching (condition-specific programs) (HLALAFAF), Adherence, Reminders & Engagement Automation (Medication/Follow-up) (HLACAEAJ)
Keywords
Where Elsa is headquartered
LocationHeadquarters
- HQ city
- Stockholm
- HQ country
- Sweden
- HQ region
- Europe
Offices2 records
Markets served
Elsa business model
Business model- GTM type
- B2B and B2C
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Marketing or Sales, Infrastructure, Operations
Revenue model
- Free Consumer App: The Elsa app is currently completely free with no in-app purchases or hidden costs. Revenue model appears to be focused on growth and data collection for research partnerships rather than direct consumer monetization.
- Healthcare Provider Partnerships: Elsa Remote Patient Monitoring enables partnerships with healthcare providers and systems for remote monitoring services
- Research Collaborations: Partnerships with pharmaceutical companies and diagnostic companies through data sharing and research collaborations
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Freemium | Others | Free app - no pricing tiers |
Go-to-market motion4 records
Distribution channels4 records
Marketing channels9 records
Elsa product offering
Product offeringCore offering
Elsa Science operates a CE-marked mobile health platform built around the Elsa Science App, which lets patients with rheumatic conditions (rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, Still's disease) log symptoms, medications, and lifestyle habits and share insights with their healthcare providers. The platform is supplemented by the Elsa Rheumatic? symptom-screening tool for early-stage detection and Elsa Remote Patient Monitoring, which gives clinicians a real-time view of patient treatment progress to support treat-to-target decisions. The app is offered free to consumers while monetization flows from healthcare-provider partnerships and research collaborations with life-science companies.
Product overview
Elsa Science is a digital health platform built around the Elsa Science App as its core product, supplemented by Elsa Rheumatic? (a symptom screening tool for early-stage rheumatic disease detection) and Elsa Remote Patient Monitoring (a healthcare-provider-facing remote monitoring feature). The platform is designed to support individuals living with chronic rheumatic diseases — primarily rheumatoid arthritis (RA), psoriatic arthritis (PsA), ankylosing spondylitis (AS), and Still's disease — by providing symptom tracking, medication logging, lifestyle habit analysis, science-based educational programs, and data-sharing capabilities with healthcare providers. The platform is CE-marked as a medical device and registered with the Swedish Medical Products Agency.
Differentiator
Problem solved
Functional benefit
Brands
- Elsa Rheumatic?: A symptom checking tool developed with patients, healthcare providers and UX designers to support and encourage people to seek treatment at an early stage of disease onset.
- Elsa Remote Patient Monitoring
Products and services
- Elsa Science App A CE-marked iOS and Android mobile application for patients with rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and Still's disease that enables symptom, medication, and lifestyle tracking, science-based educational programs, personalized plans, and data sharing with healthcare providers.
- Elsa Rheumatic? Screening Tool A symptom-checking tool developed with rheumatologists and patients that helps individuals prepare for a doctor visit when a rheumatic condition is suspected and supports early-stage detection.
- Elsa Remote Patient Monitoring A provider-facing digital tool that enables rheumatologists and healthcare teams to monitor patient treatment progress in real time and supports treat-to-target treatment decisions based on patient-reported data.
Quantifiable outcome
- Patients with chronic conditions spend 8,765 hours per year on self-care vs. only 1 hour with healthcare providers
- +1 more outcomes
Companies that use Elsa
Customer profileNamed customers4 records
Segments3 records
Ideal customer profiles3 records
Elsa technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration3 records
Feature8 records
Elsa partnerships and signals
Strategic signalPartnerships
13 partnerships are on record, tiered core and minor.
- Karolinska InstitutetcoreResearch collaboration with co-founders Lars Klareskog (Professor of Rheumatology) and Lars Alfredsson (Professor of Epidemiology) from Karolinska Institutet.
- Uppsala UniversitycoreAcademic research partnership for scientific collaboration on rheumatic disease research.
- Linköping UniversitycoreAcademic research partnership contributing to the scientific foundation of Elsa's programs.
- Leiden University (LUMC)coreInternational research collaboration with university in the Netherlands for rheumatic disease research.
- FAU (Friedrich-Alexander-Universität Erlangen-Nürnberg)minorInternational academic partner shown in collaborator logos on the website.
- ReumaNLminorDutch rheumatology patient organization partnership shown in collaborator logos.
- WestMidlandsminorUK healthcare region partnership shown in collaborator logos on rheumatic screening tool.
- Amazon Web ServicescoreCloud infrastructure provider for hosting production servers. Data processing agreements conform with GDPR requirements.
- Patient Advisory BoardscoreIncludes Hanna Svensson, Jenny Christensson, Kerstin Grentzelius, Mats Griph, Monica Persson. Provides patient perspective in product development.
- Swedish Rheumatism AssociationcorePatient organization partnership for community reach and credibility. Chairman Lotta Håkansson endorses the app.
- Unga ReumatikercoreYouth rheumatic patient organization. Chairman Cajsa Helin Hollstrand endorses the app and participates in co-development.
- Pharmaceutical CompaniescoreCollaborations with pharmaceutical companies for research projects and potential future monetization through healthcare partnerships.
- Diagnostic CompaniesminorCollaborations with diagnostic companies for research projects and ecosystem development.
Scale indicators5 records
Recent moves7 records
Expansion highlights6 records
Elsa competitors and assessment
Company assessmentDirect peers
- RheumaBuddy: Mobile-first app for rheumatology patients to track symptoms, medication, and wellbeing. Directly comparable to Elsa's core patient self-management app, including similar patient-community features and tracking tools.
- ArthritisPower (CreakyJoints / Global Healthy Living Foundation): Patient-facing research registry and app for arthritis patients developed with rheumatologists. Comparable to Elsa in combining symptom tracking with research-grade data collection for life science partners.
- Medisafe: Medication adherence and digital therapeutic platform for chronic disease patients with reminders, tracking, and provider sharing. Overlaps directly with Elsa's Medication Log, reminders, and provider data-sharing capabilities.
Broad incumbents
- Hinge Health: Larger digital MSK care platform offering virtual PT, coaching, and wearable-guided exercise programs that overlap with Elsa's chronic pain and rheumatology patient base, but at much broader scale and with enterprise payer contracts.
- Omada Health: Established virtual chronic-care platform addressing diabetes, hypertension, and musculoskeletal conditions via coaching and RPM. Comparable to Elsa in remote-monitoring-as-care-model for chronic disease, but at significantly larger scale with payer contracts.
- WellDoc (BlueLoop): FDA-cleared digital therapeutic and chronic care RPM platform for diabetes and other conditions. Comparable to Elsa as a regulated (CE-marked/FDA-cleared) software-as-medical-device for chronic disease management with provider integration.
Emerging players
- Kaia Health: Digital therapeutic for MSK pain and chronic conditions combining app-based self-management with coaching. Comparable to Elsa's CBT-based self-care programs and RPM-like remote monitoring features.
- Ada Health: AI-driven symptom assessment and triage platform with a free consumer app. Comparable to Elsa's 'Rheumatic?' screening sub-product as a digital tool that supports early care-seeking and patient navigation.
Regional players
- DigiMe: Consumer health data wallet and integrations for chronic-condition patients, similar in concept to how Elsa centralizes Apple HealthKit/Google Fit/Health Connect data for rheumatic patients.
Others
- CareCentrix (formerly MedSolutions): US-based care coordination and post-acute/home health platform. Comparable only as a payer-facing channel for chronic care RPM — relevant to Elsa's US market entry through Wisconsin but not a direct product competitor.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks5 records
Key highlights7 records
Customer concentration
Elsa social profiles
Digital presenceElsa compliance and trust
Trust signalCompliance2 records
Elsa financial estimates
Financial estimateRevenue estimate
Valuation estimate
Elsa leadership team
Management profileNumber of profiles
Profiles9 records
Elsa funding detail
Funding detailFunding overview
Funding rounds5 records
Investors7 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Elsa M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Elsa
What does Elsa do?
Elsa Science operates a CE-marked mobile health platform built around the Elsa Science App, which lets patients with rheumatic conditions (rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, Still's disease) log symptoms, medications, and lifestyle habits and share insights with their healthcare providers. The platform is supplemented by the Elsa Rheumatic? symptom-screening tool for early-stage detection and Elsa Remote Patient Monitoring, which gives clinicians a real-time view of patient treatment progress to support treat-to-target decisions. The app is offered free to consumers while monetization flows from healthcare-provider partnerships and research collaborations with life-science companies.
Is Elsa a public or private company?
Elsa is a private company. It is classified as venture growth investor backed and is currently operating.
When was Elsa founded?
Elsa was founded in 2017. It employs 11 to 50 people.
Where is Elsa based?
Elsa is headquartered in Stockholm, Sweden, in the Europe region.
How does Elsa make money?
Three revenue lines are on record. Free Consumer App is the primary driver. The others are healthcare Provider Partnerships and research Collaborations.
Who are Elsa's main competitors?
Direct peers on record are RheumaBuddy, ArthritisPower (CreakyJoints / Global Healthy Living Foundation) and Medisafe. Broad incumbents are Hinge Health, Omada Health and WellDoc (BlueLoop). Emerging players are Kaia Health and Ada Health. DigiMe is listed as a regional player. CareCentrix (formerly MedSolutions) is listed as an others.
Does Elsa have an API?
No public API is recorded for Elsa.
What industry is Elsa in?
Elsa's product category is Digital Health Patient Self-Management. Its primary akta.pro industry code is HLALABAF, Chronic Care & Remote Patient Monitoring (RPM) Platforms, with a secondary code of HLACAEAE, Patient Education, Content & Personalized Journey Orchestration. Its NAICS code is 513210 and its SIC code is 8000.